Loading clinical trials...
Loading clinical trials...
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Active treatment, dose-blinded extension study evaluating the safety and long term efficacy of sildenafil citrate in children with PAH.
Age
1 - 17 years
Sex
ALL
Healthy Volunteers
No
Pfizer Investigational Site
Palo Alto, California, United States
Pfizer Investigational Site
Palo Alto, California, United States
Pfizer Investigational Site
Stanford, California, United States
Pfizer Investigational Site
Aurora, Colorado, United States
Pfizer Investigational Site
Boston, Massachusetts, United States
Pfizer Investigational Site
Ann Arbor, Michigan, United States
Pfizer Investigational Site
St Louis, Missouri, United States
Pfizer Investigational Site
New York, New York, United States
Pfizer Investigational Site
Columbus, Ohio, United States
Pfizer Investigational Site
Charleston, South Carolina, United States
Start Date
January 1, 2004
Primary Completion Date
December 1, 2012
Completion Date
December 1, 2012
Last Updated
February 1, 2021
234
ACTUAL participants
Sildenafil citrate
DRUG
Sildenafil citrate
DRUG
Sildenafil citrate
DRUG
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT06649110
NCT07218029
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06481852